Filing Details

Accession Number:
0001144204-11-033017
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-27 18:12:43
Reporting Period:
2011-05-25
Filing Date:
2011-05-27
Accepted Time:
2011-05-27 18:12:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Pharmathene Inc PIP Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897464 John Pappajohn C/O Pharmathene, Inc.,
One Park Place, Suite 450
Annapolis MD 21401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Disposition 2011-05-25 50,000 $3.68 394,044 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share 911,164 Direct
Footnotes
  1. The shares reported in this row are owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of such shares, and this report shall not be deemed an admission that the reporting person was or is the beneficial owner of the shares for purposes of Section 13(d) or Section 16 of the Exchange Act or for any other purpose.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.65 to $3.73, inclusive. The reporting person undertakes to provide to PharmAthene, Inc., any security holder of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.